CAMBRIDGE, Mass., Nov. 7 Idenix Pharmaceuticals,Inc. (Nasdaq: IDIX) announced today that management will present at DeutscheBank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET.
The live and archived webcast of the presentation can be accessed under"Calendar of Events" in the Idenix Investor Center at http://www.idenix.com.Please log in approximately 5-10 minutes before the event to ensure a timelyconnection. The archived replay will be available on the Idenix website fortwo weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,is a biopharmaceutical company engaged in the discovery and development ofdrugs for the treatment of human viral and other infectious diseases. Idenix'scurrent focus is on the treatment of infections caused by the hepatitis Cvirus and HIV. For further information about Idenix, please refer tohttp://www.idenix.com.
Idenix Pharmaceuticals' Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
SOURCE Idenix Pharmaceuticals, Inc.